As a cancer treatment modality, thermal ablation offers the advantages of being less invasive and posing fewer post-procedural complications compared to traditional cancer therapies. It involves destroying cancerous cells by subjecting them to the appropriate amount of heat dose. In the present study, high frequency ultrasound (US) ablation is theoretically examined for effectiveness as a treatment modality for intraluminal and extracorporeal cancer treatment. Objectives of this study are to 1) develop thermal-damage correlations for a variety of cancer cells and 2) design US treatment devices, based on thermal damage correlations developed, and treatment planning protocols. To achieve these goals, thermal damage information for different cell types is first determined from earlier studies or pilot experiments. Required US doses for specific tissues are determined next through numerical experiments. Device design and estimation of thermal coagulation contours is then performed by comparing temperature-history data against the thermal-damage data for a range of device parameters. Treatment protocols are finally developed based on the analysis of the results for a range of applicable device parameters. Results are presented in terms of correlations for the volume and location of ablated tissue corresponding to a range of operating parameter values.

This content is only available via PDF.
You do not currently have access to this content.